Literature DB >> 7987805

Chromosome abnormalities in meningeal neoplasms: do they correlate with histology?

C A Griffin1, R H Hruban, P P Long, N Miller, P Volz, B Carson, H Brem.   

Abstract

Thirty-three meningeal neoplasms were karyotyped, and the results were compared with histologic features. Thirteen neoplasms had no discernible abnormality or sex chromosome loss only; nine had monosomy or structural abnormality involving only chromosome 22; and 11 had other chromosome abnormalities with or without chromosome 22 involvement. Histologic evidence of invasion was not associated with an abnormal karyotype in the three angioblastic tumors examined. All seven fibroblastic meningiomas had abnormal karyotypes, with monosomy 22 the most common change. Abnormal karyotypes were detected in 76% of syncytial and 55% of transitional meningiomas. When these results were combined with those from 259 meningeal tumors reported since 1987, abnormal karyotypes were detected in at least half of all histologic types. Chromosome changes secondary to those involving chromosome 22 may indicate additional areas of the genome that play a role in tumor progression. In the combined series, chromosome losses were most frequently observed in meningiomatous and transitional histologies; chromosomes 1, 6, 14, 18, and Y each were lost in 10 or more meningiomas, whereas only chromosome 20 was gained at the same frequency. Structural abnormalities most frequently involved chromosome 1. These changes are distinctly different from those observed in other common intracranial neoplasms, specifically astrocytic neoplasms.

Entities:  

Mesh:

Year:  1994        PMID: 7987805     DOI: 10.1016/0165-4608(94)90045-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors.

Authors:  M Cerdá-Nicolás; C López-Gineś; M Pérez-Bacete; J L Barcia-Salorio; A Llombart-Bosch
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

2.  Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas.

Authors:  Masaki Okada; Keisuke Miyake; Yoshihito Matsumoto; Nobuyuki Kawai; Katsuzo Kunishio; Seigo Nagao
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

3.  Molecular Cytogenetic Study of the NF2 Gene Deletion in Meningioma in Sudanese Patients.

Authors:  Farah Y Abdelmontalab; Elmula I Fadl; Hm Abushama; K Kreskowski; T Liehr
Journal:  Balkan J Med Genet       Date:  2013-12       Impact factor: 0.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.